Cultural Adaptation and Validation of the EORTC QLQ-BR45 to Assess Health-Related Quality of Life of Breast Cancer Patients

Ehab Barakat H.; Hussein R.R.S.; Abdullah Elberry A.; Ahmed Zaki M.; Elsherbiny Ramadan M.

doi:10.2478/afpuc-2021-0018

European Pharmaceutical Journal (Apr 2022)

Cultural Adaptation and Validation of the EORTC QLQ-BR45 to Assess Health-Related Quality of Life of Breast Cancer Patients

Ehab Barakat H.,
Hussein R.R.S.,
Abdullah Elberry A.,
Ahmed Zaki M.,
Elsherbiny Ramadan M.

Affiliations

Ehab Barakat H.: Clinical Pharmacy Department, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt
Hussein R.R.S.: Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
Abdullah Elberry A.: Clinical Pharmacology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
Ahmed Zaki M.
Elsherbiny Ramadan M.: Medical Oncology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt

DOI: https://doi.org/10.2478/afpuc-2021-0018
Journal volume & issue: Vol. 68, no. 2
pp. 41 – 48

Abstract

Read online

The European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR23 is considered a premier module for breast cancer patients that is utilised synchronously with the core questionnaire. However, new and scalable treatments on breast cancer patients’ quality of life (QoL) need a more accurate and comprehensive tool to be assessed. Therefore, the EORTC introduced the newly updated module EORTC QLQ-BR45. Hence, the current study aims to perform cultural adaptation, pilot testing and assessment of the psychometric properties of the Egyptian Arabic translation of the EORTC QLQ-BR45 module on Egyptian breast cancer patients.

Published in European Pharmaceutical Journal

ISSN: 2453-6725 (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://sciendo.com/journal/AFPUC

About the journal

Abstract

Keywords